Log In
Print
BCIQ
Print
Print this Print this
 

RE-021

  Manage Alerts
Collapse Summary General Information
Company Ligand Pharmaceuticals Inc.
DescriptionSmall molecule dual angiotensin and endothelin receptor antagonist
Molecular Target Angiotensin receptor ; Endothelin receptor
Mechanism of ActionEndothelin receptor antagonist
Latest Stage of DevelopmentPhase II
IndicationNephropathy
Partner

Retrophin Inc.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today